JP2532117B2 - 内生成長ホルモンの産生を増加させる方法 - Google Patents

内生成長ホルモンの産生を増加させる方法

Info

Publication number: JP2532117B2
Authority: JP; Japan
Prior art keywords: growth hormone; grf; administration; releasing factor; administered
Prior art date: 1986-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP62322618A

Other languages

English (en)

Japanese (ja)

Other versions

JPS63166833A (ja

Inventor

ロドニイ・ケネス・マッガフィー

ジャック・フレドリック・ワグナー

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-22

Filing date

1987-12-18

Publication date

1996-09-11

1987-12-18 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

1988-07-11 Publication of JPS63166833A publication Critical patent/JPS63166833A/ja

1996-09-11 Application granted granted Critical

1996-09-11 Publication of JP2532117B2 publication Critical patent/JP2532117B2/ja

2011-09-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Fodder In General (AREA)
Feed For Specific Animals (AREA)

JP62322618A 1986-12-22 1987-12-18 内生成長ホルモンの産生を増加させる方法 Expired - Lifetime JP2532117B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94543786A	1986-12-22	1986-12-22
US945437		1986-12-22

Publications (2)

Publication Number	Publication Date
JPS63166833A JPS63166833A (ja)	1988-07-11
JP2532117B2 true JP2532117B2 (ja)	1996-09-11

Family

ID=25483086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP62322618A Expired - Lifetime JP2532117B2 (ja)	1986-12-22	1987-12-18	内生成長ホルモンの産生を増加させる方法

Country Status (11)

Country	Link
JP (1)	JP2532117B2 (de)
AU (1)	AU601532B2 (de)
BE (1)	BE1000626A3 (de)
CA (1)	CA1317222C (de)
DE (1)	DE3743129C2 (de)
FR (1)	FR2608430B1 (de)
GB (1)	GB2198643B (de)
HK (1)	HK35793A (de)
IT (1)	IT1223542B (de)
NZ (1)	NZ222982A (de)
ZA (1)	ZA879528B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6486134B2 (en) *	1999-09-17	2002-11-26	Leadergene Limited	Gene treatment to enhance feed efficiency and growth rate of livestock

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3436819A1 (de) *	1984-10-06	1986-04-17	Hoechst Ag, 6230 Frankfurt	Arzneimittel mit grf-wirkung
ZA866026B (en) *	1985-08-12	1988-04-27	Syntex Inc	Bovine growth hormone releasing factor derivative

1987
- 1987-12-17 CA CA000554603A patent/CA1317222C/en not_active Expired - Fee Related
- 1987-12-18 NZ NZ222982A patent/NZ222982A/en unknown
- 1987-12-18 GB GB8729492A patent/GB2198643B/en not_active Expired - Lifetime
- 1987-12-18 ZA ZA879528A patent/ZA879528B/xx unknown
- 1987-12-18 JP JP62322618A patent/JP2532117B2/ja not_active Expired - Lifetime
- 1987-12-18 FR FR878717733A patent/FR2608430B1/fr not_active Expired
- 1987-12-18 IT IT23101/87A patent/IT1223542B/it active
- 1987-12-18 DE DE3743129A patent/DE3743129C2/de not_active Expired - Fee Related
- 1987-12-18 AU AU82700/87A patent/AU601532B2/en not_active Ceased
- 1987-12-22 BE BE8701473A patent/BE1000626A3/fr not_active IP Right Cessation
1993
- 1993-04-15 HK HK357/93A patent/HK35793A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA879528B (en)	1989-08-30
AU601532B2 (en)	1990-09-13
FR2608430B1 (fr)	1989-11-03
DE3743129A1 (de)	1988-06-30
GB2198643B (en)	1990-10-10
DE3743129C2 (de)	1997-05-07
HK35793A (en)	1993-04-23
GB2198643A (en)	1988-06-22
AU8270087A (en)	1988-06-23
JPS63166833A (ja)	1988-07-11
BE1000626A3 (fr)	1989-02-21
CA1317222C (en)	1993-05-04
IT8723101A0 (it)	1987-12-18
GB8729492D0 (en)	1988-02-03
NZ222982A (en)	1990-04-26
FR2608430A1 (fr)	1988-06-24
IT1223542B (it)	1990-09-19

Similar Documents

Publication	Publication Date	Title
Peel et al.	1981	Effect of exogenous growth hormone on lactational performance in high yielding dairy cows
KR100543190B1 (ko)	2006-06-23	향상된생물학적효능을갖는키메라성지방체-프로-지알에프유사체
Tanner	1972	Human growth hormone
Ketterer et al.	1957	The pituitary growth hormone and metabolic processes
EP0289186A2 (de)	1988-11-02	Methode zur Erhöhung der Wachstumsrate und zur Steigerung der Futterleistungsfähigkeit bei Vieh
JP2620417B2 (ja)	1997-06-11	生物学的活性を有するポリペプチドを持続的に放出する組成物
US4558033A (en)	1985-12-10	Potentiation of the effects of insulin by peptides
Skyrud et al.	1989	Effects of recombinant human growth hormone and insulin-like growth factor 1 on body growth and blood metabolites in brook trout (Salvelinus fontinalis)
JPS63303930A (ja)	1988-12-12	インシユリンおよびインシユリン誘導体の混合結晶
Vanderkooi et al.	1995	Comparison of growth hormone-releasing factor and somatotropin: the somatotropic axis in lactating primiparous cows
Gopinath et al.	1989	Effects of porcine growth hormone on glucose metabolism of pigs: I. Acute and chronic effects on plasma glucose and insulin status
BAUMANN et al.	1992	Increase of glomerular filtration rate and renal plasma flow by insulin‐like growth factor‐1 during euglycaemic clamping in anaesthetized rats
JP2532117B2 (ja)	1996-09-11	内生成長ホルモンの産生を増加させる方法
Baile et al.	1969	Effects of Secret in and Cholecystokinin-Pancreozymin on Pancreatic Juice and Insulin Secretion of Goats
Louis et al.	1972	Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetic patients
Vilhardt et al.	1986	The mechanism of the effect of oxytocin on plasma concentrations of glucose, insulin and glucagon in conscious dogs
CS272772B2 (en)	1991-02-12	Method of sound, physiologically normal farming animal's mamma parenchyma's growth increase
US4997825A (en)	1991-03-05	Synergistic treatment method
Sinha et al.	1979	Serum and pituitary concentrations of growth hormone and prolactin in pygmy mice
Pieters et al.	1984	Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration
Read et al.	1992	Achlorhydria induced changes in gastrin, somatostatin, H+/K+-ATPase and carbonic anhydrase in the sheep
CA1313134C (en)	1993-01-26	Endogenous growth hormone
Mimeo et al.	1994	Effects of intravenous infusions of cholecystokinin-8 and pentagastrin on plasma concentrations of insulin and glucagon in sheep
Stevenson et al.	1988	The synthetic human growth hormone fragment (32–38) increases glucose uptake in the conscious dog
Bloom et al.	1985	Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves.